Results 241 to 250 of about 15,825 (259)

Treatment of muscle‐invasive and advanced bladder cancer in 2020

Ca-A Cancer Journal for Clinicians, 2020
Vaibhav G Patel, William K Oh, Matthew D Galsky   +2 more
exaly  

Allosteric regulation of [3H]acetylcholine binding to m2 muscarinic receptors

Life Sciences, 1993
L. First, John Ellis, M. Seidenberg, A.L. Gnagey   +3 more
openaire   +2 more sources

Tumor board presentation of a woman with metastatic, hormone receptor‐positive, mismatch repair‐deficient endometrial cancer

Ca-A Cancer Journal for Clinicians, 2022
Gini F Fleming, Jennifer A Bennett
exaly  

Evolving standards of care and new challenges in the management of HER2‐positive breast cancer

Ca-A Cancer Journal for Clinicians, 2020
Ciara C O’sullivan, Grace D Cullen, Grace M Choong   +2 more
exaly  

Erratum to `Interactions of agonists with an allosteric antagonist at muscarinic acetylcholine M2 receptors'

European Journal of Pharmacology, 1997
Arthur Christopoulos, Alfred Lanzafame, Fred Mitchelson   +2 more
openaire   +2 more sources

Desensitization of the M2 muscarinic acetylcholine receptor: Effects of dominant-negative βARK1

Life Sciences, 1995
M. Marlene Hosey, Robin Pals-Rylaarsdam, Jeffrey L. Benovic   +2 more
openaire   +2 more sources

Breast Cancer—Major changes in the American Joint Committee on Cancer eighth edition cancer staging manual

Ca-A Cancer Journal for Clinicians, 2017
Elizabeth A Mittendorf, Hope S Rugo, Gabriel N Hortobagyi   +2 more
exaly  

M2 Muscarinic Acetylcholine Receptor

2007
openaire   +1 more source

Obesity and adverse breast cancer risk and outcome: Mechanistic insights and strategies for intervention

Ca-A Cancer Journal for Clinicians, 2017
Joyce Slingerland, Manuel Picon-ruiz, Cynthia Morata-tarifa   +2 more
exaly  

Regulation of an inwardly rectifying potassium channel by the M2 muscarinic acetylcholine receptor

Life Sciences, 1995
E.G. Peralta, M.T. Kunkel
openaire   +2 more sources